Stock Analysis, Dividends, Split History

GUAA / Guaranty Bancorp, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)542.21
Enterprise Value ($M)469.87
Book Value ($M)418.95
Book Value / Share14.29
Price / Book1.29
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Stock Shares Outstanding 29,222,264
Common Shares Outstanding 29,305,602
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.10
Return on Assets (ROA)0.01
Return on Equity (ROE)0.11
Balance Sheet (mrq) ($M)
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Net Income38.62
Earnings Per Share Basic1.38
Earnings Per Share Diluted1.36
Cash Flow Statement (mra) ($M)
Cash From Operations51.84
Cash from Investing-187.13
Cash from Financing51.84
Identifiers and Descriptors
Central Index Key (CIK)1324410

Split History

Stock splits are used by Guaranty Bancorp, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Zions' (ZION) Ratings Affirmed by Moody's, Outlook Positive

2018-08-08 zacks
Zions Bancorporation (ZION - Free Report) and its subsidiary’s ratings have been affirmed by Moody’s Investors Service, the rating arm of Moody’s Corporation (MCO - Free Report) . The outlook for the company has been upgraded to positive from stable. Zions’ senior unsecured rating has been affirmed at (P)Baa3. Its subsidiary’s Baseline Credit Assessment (BCA) stands at baa2 while its issuer rating has been affirmed at Baa3. (6-0)

Moody's to Buy Omega Performance to Enhance Credit Platform

2018-08-08 zacks
In an effort to enhance online credit training platform, Moody's Corporation (MCO - Free Report) has agreed to acquire Omega Performance, a business unit of TwentyEighty Inc. While the deal is expected to be completed within 30 days, it is not likely to have any material impact on Moody’s financials in 2018. Serving more than 300 customers, Omega Performance offers a wide range of online credit training courses. (6-0)

4 Reasons to Buy People's Utah Bancorp (PUB) Stock Right Now

2018-07-06 zacks
People's Utah Bancorp (PUB - Free Report) offers a profitable investment opportunity, driven by steady earnings growth and solid prospects. Also, easing margin pressure, supported by the improvement in the interest-rate scenario, is expected to aid top-line growth. The company is also witnessing upward estimate revisions, reflecting analysts’ optimism about its growth prospects. Over the last 60 days, the Zacks Consensus Estimate for 2018 has been raised nearly 1%. (1-0)

5 Reasons to Invest in East West Bancorp (EWBC) Stock Now

2018-06-22 zacks
East West Bancorp, Inc. (EWBC - Free Report) is well positioned for growth, supported by continued rise in loans and deposit balances, as well as increasing interest rates. Also, the company’s dividend payout policy seems impressive. Thus, it seems to be a wise idea to add the stock to your portfolio now. The company’s Zacks Consensus Estimate for the current-year earnings has been revised 3.1% upward over the last 60 days, reflecting analysts’ optimism regarding its earnings growth potential. (9-0)

Deals of the day-Mergers and acquisitions

2018-05-23 reuters
May 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday: (67-0)